APA (7th ed.) Citation

Anne Barbot, Michele Lheritier-Barrand, Margarita Murrieta-Aguttes, Maud Leonetti, Jimmy Vernaz, Song Huang, . . . Bernadett Boda. (2024). Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Anne Barbot, Michele Lheritier-Barrand, Margarita Murrieta-Aguttes, Maud Leonetti, Jimmy Vernaz, Song Huang, Samuel Constant, and Bernadett Boda. Establishment of a Human Nasal Epithelium Model of Histamine-induced Inflammation to Assess the Activity of Fexofenadine as an Inverse Agonist and Its Link to Clinical Benefit. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Anne Barbot, et al. Establishment of a Human Nasal Epithelium Model of Histamine-induced Inflammation to Assess the Activity of Fexofenadine as an Inverse Agonist and Its Link to Clinical Benefit. Frontiers Media S.A., 2024.